S. Muoio & Co’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,000
Closed -$330K 85
2022
Q2
$330K Buy
+6,000
New +$315K 0.47% 55

Other funds holding SRRA

S. Muoio & Co's SRRA Position: Q3 2022 in Review

S. Muoio & Co sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 6,000 shares — an estimated $330K sold.

S. Muoio & Co first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $330K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • S. Muoio & Co reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • S. Muoio & Co sold 6,000 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $330K.
  • S. Muoio & Co first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • S. Muoio & Co's Sierra Oncology, Inc. Common Stock position peaked at $330K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on S. Muoio & Co's 13F filing for Q3 2022, filed 14 Nov 2022.